Home private section Acceder a su Área privada   |  

Organized by


  • SDDN

    CIC BIOGUNE

    UPV EHU

Collaborators


  • REDE FAR

    SLAS

Technical Secretariat


  • LIDERA MEDICAL

 
Recargar   Disminuir tamaño de letra   Aumentar tamaño de letra   Imprimir texto
Home / Scientific Programme / Scientific Programme

Scientific Programme


SESSION 1.  COMPUTATIONAL PREDICTIVE METHODS FOR DRUG DISCOVERY

Predictive methods are widely used in many stages throughout the drug discovery process. This session will feature the use of innovative and state-of-the-art computational methods, algorithms and technologies ranging from a better-informed selection of new targets to the acceleration of medicinal chemistry and the prediction of potential liabilities of the new lead molecules.



SESSION 2. DISEASED RELEVANT MODEL SYSTEMS FOR PHENOTYPIC DRUG DISCOVERY


The selection of a suitable model system is critical in the successful advancement of novel therapeutic approaches to disease. The development of models and assays that recapitulate the full complexity of the disease they intend to represent, and the ability to scale them up to screening campaigns remains a big challenge in the drug discovery field. The session will bring together experts in the field presenting innovative models across different disease areas.
 


SESSION 3.  ENTREPRENEURSHIP AND FINANCING DRUG DISCOVERY


The biotechnology industry, including start-up companies originated from Public Research Organisations and Academic Institutions, is responsible today for a considerable proportion of breakthroughs in the treatment of unmet medical needs, having a great impact on Society and the lives of millions of people. In this session, we will have the opportunity to learn from the success of several initiatives with very different origins and technologies, but however all sharing some common features: innovation, enthusiasm, perseverance, and a bit of genuine altruisms.
 

 © 2018  Brigantia | CONGRESS.NET